Published in J Thromb Haemost on March 12, 2010
Emerging roles for platelets as immune and inflammatory cells. Blood (2014) 1.56
Platelet glycoprotein Ib-IX as a regulator of systemic inflammation. Arterioscler Thromb Vasc Biol (2014) 1.50
Platelets: a critical link between inflammation and microvascular dysfunction. J Physiol (2011) 1.10
Insult-dependent effect of bone marrow cell therapy on inflammatory response in a murine model of extrapulmonary acute respiratory distress syndrome. Stem Cell Res Ther (2013) 0.86
Microvesicles at the crossroads between infection and cardiovascular diseases. J Cardiovasc Pharmacol (2012) 0.86
Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in Mice. PLoS One (2016) 0.78
Association of serum immunoglobulin G (IgG) levels against two periodontal pathogens and prothrombotic state: a clinical pilot study. Thromb J (2010) 0.77
Proteome analysis of mast cell releasates reveals a role for chymase in the regulation of coagulation factor XIIIA levels via proteolytic degradation. J Allergy Clin Immunol (2016) 0.75
Histones stimulate von Willebrand factor release in vitro and in vivo. Haematologica (2016) 0.75
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity (1999) 17.40
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood (2003) 5.22
A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A (1998) 3.54
Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock (2000) 3.12
Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol (2005) 2.47
Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med (2003) 2.15
Role of LPS in the hepatic microvascular dysfunction elicited by cecal ligation and puncture in mice. J Hepatol (2007) 2.07
Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit Care Med (2006) 2.06
Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci U S A (2009) 1.86
Determination of volumetric flow in capillary tubes using an optical Doppler velocimeter. Microvasc Res (1987) 1.62
Role of Toll-like receptors in the development of sepsis. Shock (2008) 1.57
Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol (2007) 1.54
Evaluation of endotoxin models for the study of sepsis. Shock (2005) 1.47
Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis. Haematologica (2007) 1.45
Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost (2006) 1.28
Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil-independent mechanism. Am J Physiol Heart Circ Physiol (2005) 1.27
Tissue factor: a mediator of inflammatory cell recruitment, tissue injury, and thrombus formation in experimental colitis. J Exp Med (2007) 1.27
Mouse cremaster venules are predisposed to light/dye-induced thrombosis independent of wall shear rate, CD18, ICAM-1, or P-selectin. Microcirculation (2004) 1.23
TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism. Am J Physiol Heart Circ Physiol (2010) 1.22
Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants. Crit Care Med (2001) 1.22
The role of microvascular thrombosis in sepsis. Anaesth Intensive Care (2004) 1.21
Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis. Intensive Care Med (2008) 1.14
Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation. Thromb Haemost (2005) 1.10
Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo model. J Antimicrob Chemother (2002) 1.08
Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun (2001) 1.08
Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation: synergism of TLR2 and TLR4. Arterioscler Thromb Vasc Biol (2007) 1.06
Sepsis induces an increase in thick ascending limb Cox-2 that is TLR4 dependent. Am J Physiol Renal Physiol (2007) 1.05
Role of endotoxin in the expression of endothelial selectins after cecal ligation and perforation. Am J Physiol Regul Integr Comp Physiol (2000) 1.02
Expression of toll-like receptors in neonatal sepsis. Pediatr Res (2005) 0.98
Animal and human models for sepsis. Ann Med (2002) 0.96
von Willebrand factor is a major determinant of ADAMTS-13 decrease during mouse sepsis induced by cecum ligation and puncture. J Thromb Haemost (2009) 0.94
The influence of the haematocrit on primary haemostasis in vitro. Thromb Haemost (2005) 0.93
The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood (2006) 0.93
Differential role of von Willebrand factor and P-selectin on microvascular thrombosis in endotoxemia. Arterioscler Thromb Vasc Biol (2008) 0.92
Blood flow resistance during hemodilution: effect of plasma composition. Cardiovasc Res (1998) 0.92
Nitric oxide modulates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. Am J Physiol Heart Circ Physiol (2002) 0.90
Fluids reverse the early lipopolysaccharide-induced albumin leakage in rodent mesenteric venules. Intensive Care Med (2004) 0.86
Regulation of microvascular thromboembolism in vivo. Microcirculation (2005) 0.82
Renal microthrombosis following endotoxin infusion may be mediated by lipoxygenase products. Circ Shock (1987) 0.81
Fatal meningococcal septicemia. Arch Pathol Lab Med (1977) 0.81
Countervailing influence of tumor necrosis factor-alpha and nitric oxide in endotoxemia. J Am Soc Nephrol (2001) 0.80
Ex vivo evaluation of erythrocytosis-enhanced platelet thrombus formation using the cone and plate(let) analyzer: effect of platelet antagonists. Br J Haematol (2004) 0.78
The inflammatory response to endotoxin. J Pathol (1979) 0.78
Acetyl salicylic acid alleviates increased susceptibility to thrombosis in pial microvessels of dehydrated mice. J Vet Med Sci (1994) 0.77
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol (1994) 3.22
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation. Int J Radiat Oncol Biol Phys (1995) 2.05
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med (1999) 1.88
Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment. Ann Oncol (2009) 1.52
Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus. Arthritis Rheum (1991) 1.50
Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc Natl Acad Sci U S A (2001) 1.42
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen. Bone Marrow Transplant (2005) 1.39
Barriers to health care for abused Latina and Asian immigrant women. J Health Care Poor Underserved (2000) 1.37
Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants. J Clin Oncol (1997) 1.21
Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids (1991) 1.18
Purification and characterization of acylation stimulating protein. J Biol Chem (1989) 1.17
A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels. J Clin Oncol (1989) 1.13
Racemose cysticercus in human brain. A case report. Am J Trop Med Hyg (1981) 1.10
Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease. Int J Radiat Oncol Biol Phys (1992) 1.06
The politics and prevention of gun violence. West J Med (2000) 1.06
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma. Ann Oncol (2003) 1.05
Four-vessel umbilical cord without congenital abnormalities. South Med J (1984) 1.03
Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res (1990) 1.01
Influence of dietary fiber on fecal excretion of volatile fatty acids by human adults. J Nutr (1983) 0.99
Growth, sporulation and enterotoxin production by Clostridium perfringens type A in the presence of human bile salts. FEMS Microbiol Lett (1991) 0.96
Abnormal platelet function in C3-deficient mice. J Thromb Haemost (2009) 0.96
Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease. J Clin Oncol (1997) 0.96
Isolation and purification of two immunodominant antigens from Nocardia brasiliensis. J Clin Microbiol (1992) 0.95
Sporulation and enterotoxin production by Clostridium perfringens type A at 37 and 43 degrees C. Appl Environ Microbiol (1992) 0.95
Laboratory-acquired meningitis caused by Brucella abortus strain 19. J Infect Dis (1986) 0.94
Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int (1996) 0.94
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma. Semin Oncol (2000) 0.94
Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial. Ann Oncol (2000) 0.94
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma. Ann Oncol (2001) 0.94
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival. Ann Oncol (1999) 0.92
Letting compassion open the door: battered women's disclosure to medical providers. Camb Q Healthc Ethics (1995) 0.92
Studies on the relationship between HLA DR4 and in vitro IgM rheumatoid factor production. Clin Immunol Immunopathol (1983) 0.92
Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma. Am J Med (1989) 0.91
Non-steroidal anti-inflammatory agent inhibit the synthesis of IgM rheumatoid factor in vitro. Lancet (1982) 0.91
Proximal 10q trisomy: a new case with anal atresia. J Med Genet (2000) 0.90
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma. J Clin Oncol (1992) 0.90
Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas. Ann Oncol (1994) 0.90
Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial. Br J Haematol (1997) 0.89
Temperature-metabolism relations in the cotton-top tamarin (Saguinus oedipus) model for ulcerative colitis. J Med Primatol (1994) 0.88
Prognostic value of serum beta-2 microglobulin in low-grade lymphoma. Ann Intern Med (1991) 0.88
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy? Clin Lymphoma (2001) 0.88
Injury-control education in six U.S. medical schools. Acad Med (1998) 0.86
Characterization of the suppressor activity in lymphocytes from patients with common variable hypogammaglobulinemia: evidence for an associated primary B-cell defect. Clin Immunol Immunopathol (1983) 0.86
Regulation of IgM rheumatoid factor production in lymphocyte cultures from young and old subjects. J Immunol (1982) 0.86
Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse. J Clin Oncol (1991) 0.85
The microvasculature as a dynamic regulator of volume and solute exchange. Clin Exp Pharmacol Physiol (2000) 0.85
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma. J Clin Oncol (1996) 0.85
Influence of elevated temperature on starch hydrolysis by enterotoxin-positive and enterotoxin-negative strains of Clostridium perfringens type A. Appl Environ Microbiol (1992) 0.85
alpha-Interferon increases immunoglobulin production in cultured human mononuclear leukocytes. J Immunol (1983) 0.84
Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma. Leuk Lymphoma (1995) 0.84
Increased proportion of responders to a murine anti-CD3 monoclonal antibody of the IgG1 class in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1993) 0.84
The effect of a plasma protein fraction on lipid synthesis in cultured skin fibroblasts from normals and patients with hyperapobetalipoproteinemia. Clin Invest Med (1988) 0.84
Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patients. Leuk Lymphoma (2000) 0.84
Stimulation of fatty acid uptake and triglyceride synthesis in human cultured skin fibroblasts and adipocytes by a serum protein. Biochem Biophys Res Commun (1987) 0.84
Polysomy of chromosome 12 in 60 patients with non-Hodgkin's lymphoma assessed by fluorescence in situ hybridization: differences between follicular and diffuse large cell lymphoma. Genes Chromosomes Cancer (1994) 0.83
Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma. Leuk Lymphoma (1997) 0.83
Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial. Oncology (Williston Park) (2002) 0.83
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma. Ann Oncol (1998) 0.83
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma. Ann Oncol (2007) 0.83
Hemangioma of the ovary in an 81-year-old woman. South Med J (1979) 0.83
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma. Br J Haematol (1998) 0.82
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma. J Clin Oncol (1994) 0.82
ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease. Blood (1999) 0.82
Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma. J Clin Oncol (1995) 0.82
Abnormal immunoglobulin and rheumatoid factor synthesis by blood lymphocytes in patients with primary Sjögren's syndrome. Arthritis Rheum (1986) 0.82
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma. Leuk Lymphoma (1998) 0.82
Inhibition of rheumatoid factor production by non-steroidal anti-inflammatory drugs. Inflammation (1984) 0.81
Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features. Blood (1999) 0.81
Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas. Int J Radiat Oncol Biol Phys (2000) 0.81
Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981. Ann Oncol (2000) 0.81
Characterization of the suppressor cell activity in human cord blood lymphocytes. J Clin Invest (1981) 0.81
Noise reduction in ultrasonic NDT using undecimated wavelet transforms. Ultrasonics (2006) 0.81
Atropine prophylaxis of the postreperfusion syndrome in liver transplantation. Transplant Proc (1999) 0.80
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy. Ann Oncol (1994) 0.80
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease. Semin Hematol (1988) 0.79
Mesenteric venous thrombosis after appendicectomy in a child: clinical case and review of the literature. J Pediatr Surg (1998) 0.79
Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1. Thromb Haemost (1987) 0.79
Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome. Leuk Lymphoma (2001) 0.79
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma. Leuk Lymphoma (1999) 0.79
Irinotecan in relapsed or refractory non-Hodgkin's lymphoma. Oncology (Williston Park) (2001) 0.79
Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy. Blood (1991) 0.79
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas. Int J Radiat Oncol Biol Phys (2001) 0.78
Small noncleaved cell lymphoma in adults: superior results for stages I-III disease. J Clin Oncol (1990) 0.78
Clinicians, intimate partner violence, and opportunities. West J Med (2001) 0.78
Protein tyrosine kinase activity in T lymphocytes from patients with systemic lupus erythematosus. J Autoimmun (1998) 0.78
Organisation of the cerebellar nucleus of the dogfish, Scyliorhinus canicula L.: a light microscopic, immunocytochemical, and ultrastructural study. J Comp Neurol (1996) 0.78
Medium pH, carbon and nitrogen concentrations modulate the phosphate solubilization efficiency of Penicillium purpurogenum through organic acid production. J Appl Microbiol (2011) 0.77
A protein tyrosine kinase associated with the ATP-dependent inactivation of adipose diacylglycerol acyltransferase. Lipids (1996) 0.77
Immunoglobulin production by peripheral blood mononuclear cells in patients with alcoholic liver disease. Clin Exp Immunol (1984) 0.77
Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma. J Natl Cancer Inst (1988) 0.77
Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease. Leuk Lymphoma (1998) 0.77
Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes from patients with systemic lupus erythematosus. Lupus (1998) 0.77
Structural diversity of lithium neopentoxide compounds. Inorg Chem (2001) 0.77
Distribution of anti-F(ab')2 antibodies and the 16/6 idiotype in systemic lupus erythematosus (SLE) probands and kindreds. J Clin Immunol (1989) 0.77
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy. Int J Radiat Oncol Biol Phys (2001) 0.77
Right axillary artery bullet embolus following gunshot wound of the back. J Trauma (1975) 0.76